Total buying$00 buys
CORT
CORCEPT THERAPEUTICS INC
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$6.18M12 sells
Net open-market−$6.18MBuying minus selling
Active insiders6Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 16, 2026
Open-market transaction mix · 12 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
| Oct 2026 | 0 | 12 | 1 | $0 | $6.18M | -$6.18M |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (5)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- WN-$1.1M
- MS-$1.0M
- LD-$991.9k
- VW-$787.2k
CORT transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
CORTCORCEPT THERAPEUTICS INC | Wilson James NDIR | S · sale10b5-1 detectedSEC filing ↗ | -$34.8kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Wilson James NDIR | S · sale10b5-1 detectedSEC filing ↗ | -$351kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Wilson James NDIR | S · sale10b5-1 detectedSEC filing ↗ | -$761kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Vieira Roberto WandenkolkPRES | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Vieira Roberto WandenkolkPRES | S · sale10b5-1 detectedSEC filing ↗ | -$600kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Vieira Roberto WandenkolkPRES | S · sale10b5-1 detectedSEC filing ↗ | -$241kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Vieira Roberto WandenkolkPRES | S · sale10b5-1 detectedSEC filing ↗ | -$125kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Vieira Roberto WandenkolkPRES | M · exercise10b5-1 detectedSEC filing ↗ | $180kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Lyon Joseph DouglasSR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Lyon Joseph DouglasSR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Lyon Joseph DouglasSR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Lyon Joseph DouglasSR | S · sale10b5-1 detectedSEC filing ↗ | -$552kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Lyon Joseph DouglasSR | S · sale10b5-1 detectedSEC filing ↗ | -$514kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Lyon Joseph DouglasSR | M · exercise10b5-1 detectedSEC filing ↗ | $112kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Lyon Joseph DouglasSR | M · exercise10b5-1 detectedSEC filing ↗ | $45.5kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Lyon Joseph DouglasSR | S · sale10b5-1 detectedSEC filing ↗ | -$93.4kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Lyon Joseph DouglasSR | M · exercise10b5-1 detectedSEC filing ↗ | $10.9kView disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Maduck SeanSR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Maduck SeanSR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
CORTCORCEPT THERAPEUTICS INC | Maduck SeanSR | S · sale10b5-1 detectedSEC filing ↗ | -$1.01MView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period27transactionstxns
- M · Option exercise · dominant12 · 44%
- S · Open-market sells12 · 44%
- G · Gifts2 · 7%
- A · Grants / awards1 · 4%
Activity by reported role
A joint filing can contribute to multiple rolesSR17
PRES5
Director3
CBO2
Reported Holdings After
Separated by insider, security, and ownership type
Lyon Joseph DouglasCommon Stock · Direct
5,683Oct 02, 2026
Maduck SeanCommon Stock · Direct
9,938Oct 02, 2026
Vieira Roberto WandenkolkCommon Stock · Direct
3,946Oct 02, 2026
Lyon Joseph DouglasStock option (right to buy) · Direct
44,167Oct 02, 2026
Wilson James NCommon Stock · Indirect · James N. Wilson and Pamela D. Wilson Trust
1,054,543Oct 15, 2026
Maduck SeanStock option (right to buy) · Direct
41,986Oct 02, 2026
Robb Gary CharlesCommon Stock · Direct
14,056Sep 24, 2026
Robb Gary CharlesCommon Stock · Indirect · Custodial Account for Child
20,571Sep 24, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
CORCEPT THERAPEUTICS INC Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at CORCEPT THERAPEUTICS INC?
WILSON JAMES N, Vieira Roberto Wandenkolk, Lyon Joseph Douglas, Maduck Sean, Gunn Justin Frederick, Robb Gary Charles.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Wilson James N reported a sale on Oct 15, 2026 valued at $34.8k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $6,182,862.66. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.